Security key
91864C107
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS)
CUSIP: 91864C107
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / American Depositary Shares, each representing one ordinary share
- Total 13F shares
- 9,914,647
- Total 13F value
- $11,759,119
- Share change
- +216,438
- SEC-reported price per share
- $1.40
- Number of holders
- 18
- Value change
- +$303,322
- Number of buys
- 5
- Number of sells
- 2
- Shares outstanding
- 40,291,821
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
18
Top holders
10
BRNS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Barinthus Biotherapeutics plc. SEC filings
Barinthus Biotherapeutics plc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 91864C107
Recent filing periods:
Ownership snapshot
Top reported holders of BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
M&G Plc
Disclosed value leader
M&G Plc
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
M&G Plc leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens M&G Plc's linked filing trail.
Comparable ownership
Top 5
M&G Plc
13%
Alphabet Inc.
3.8%
HSG Holding Ltd
3.5%
DC Funds, LP
1.6%
BlueCrest Capital Management Ltd
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| M&G Plc |
13F
Company
|
13%
|
$10,394,698
5,197,349 shares
|
— | 31 Mar 2024 |
| Alphabet Inc. |
13F
Company
|
3.8%
|
$3,602,472
1,513,644 shares
|
— | 31 Mar 2024 |
| HSG Holding Ltd |
13F
Company
|
3.5%
|
$3,622,206
1,420,473 shares
|
— | 31 Mar 2024 |
| DC Funds, LP |
13F
Company
|
1.6%
|
$1,528,446
642,204 shares
|
— | 31 Mar 2024 |
| BlueCrest Capital Management Ltd |
13F
Company
|
1.3%
|
$1,291,562
542,673 shares
|
— | 31 Mar 2024 |
| Baird Financial Group, Inc. |
13F
Company
|
0.42%
|
$399,138
167,705 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
9,914,647
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
15
Q2 2024 holders
18
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend